ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$9.81
+0.31 (+3.21%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+259.0% upside
Low Target
$21.76
Average Target
$35.22
High Target
$46.82
Current Price
$9.81
Current
$9.81
$9.81
Target
$35.22
$35.22
$21.76
$35.22 avg
$46.82
Scenario Analysis
Bear Case
$21.76
121.8%
Low target
Base Case
$35.22
+259.0%
Avg target
Bull Case
$46.82
+377.3%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$20.46
-52.0% from high
52-Week Low
$7.21
+36.1% from low
50-Day SMA
$17.86
-45.1% vs SMA
200-Day SMA
$17.61
-44.3% vs SMA
RSI (14)
42.2
Neutral
Target vs 52W High
$35.22
+72.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |